Atara Biotherapeutics has now faced a second setback after getting a complete re...
Chinese biotechs InnoCare Pharma and KeyMed Biosciences have licensed the intern...
Disc Medicine finalised the pivotal Phase III trial design of bitopertin in eryt...
The FDA reported that six patients died after being injected with Teva’s Copaxon...
Emcure Pharmaceuticals has opened its new formulation research and development (...
AbbVie and Neomorph are set to enter a partnership and option-to-license agreeme...
The Pharmaceutical Technology Excellence Awards winners have been announced! Dow...
The year ahead in clinical trials looks set to be one that is challenged and inf...
Biogen’s applications for the higher dose regimen of spinal muscular atrophy (SM...
A new report dives into the evolving clinical trial landscape and transformative...
The FDA has granted orphan drug designation (ODD) to Zai Lab’s ZL-1310, aimed at...
Emergent Biosolutions (Gaithersburg, US) has purchased US and Canadian rights to...
A groundbreaking statistical tool has emerged that enhances the ability to predi...
Marcus Freeman Receives Prestigious Coach of the Year Award at the 2025 Paul “Be...
The evolution of contemporary sports has brought forth a profound understanding ...
Researchers at The Ohio State University Wexner Medical Center, in collaboration...
